Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
opnMe.com: a digital initiative for sharing tools with the biomedical research community.
Gollner A, Köster M, Nicklin P, Trieselmann T, Klein E, Vlach J, Heine C, Grundl M, Ramharter J, Wyatt D, Chaturvedi M, Ciulli A, Carter KC, Müller S, Bischoff D, Ettmayer P, Haaksma E, Mack J, McConnell D, Stenkamp D, Weinstabl H, Zentgraf M, Wood CR, Montel F. Gollner A, et al. Among authors: ciulli a. Nat Rev Drug Discov. 2022 Jul;21(7):475-476. doi: 10.1038/d41573-022-00071-9. Nat Rev Drug Discov. 2022. PMID: 35459938 No abstract available.
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7.
Zoppi V, Hughes SJ, Maniaci C, Testa A, Gmaschitz T, Wieshofer C, Koegl M, Riching KM, Daniels DL, Spallarossa A, Ciulli A. Zoppi V, et al. Among authors: ciulli a. J Med Chem. 2019 Jan 24;62(2):699-726. doi: 10.1021/acs.jmedchem.8b01413. Epub 2018 Dec 28. J Med Chem. 2019. PMID: 30540463 Free PMC article.
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type.
Tarantelli C, Cannas E, Ekeh H, Moscatello C, Gaudio E, Cascione L, Napoli S, Rech C, Testa A, Maniaci C, Rinaldi A, Zucca E, Stathis A, Ciulli A, Bertoni F. Tarantelli C, et al. Among authors: ciulli a. Explor Target Antitumor Ther. 2021;2(6):586-601. doi: 10.37349/etat.2021.00065. Epub 2021 Dec 31. Explor Target Antitumor Ther. 2021. PMID: 36046113 Free PMC article.
150 results